 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IceCure's ProSense Deepens Regulatory Approval in India IceCure's ProSense Deepens Regulatory Approval in India PR Newswire CAESAREA, Israel, Nov. 29, 2023 ProSense is already marketed and sold in...

IceCure's ProSense Deepens Regulatory Approval in India

IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate IceCure System Successfully Treated Kidney Cancer Tumor with 92...

IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate

IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript...

IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript

IceCure Medical Reports Financial Results as of and for the Nine Months Ended September 30, 2023, and Provides Update on Recent Operational Highlights IceCure Medical Reports Financial Results as of...

IceCure Medical Reports Financial Results as of and for the Nine Months Ended September 30, 2023, and Provides Update on Recent Operational Highlights

IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023 PR...

IceCure Medical to Report Third Quarter 2023 Financial & Operational Results on November 15, 2023

Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense Cryoablation System Substantial Evidence-Based Data Currently Being Generated by 19...

Substantial Evidence-Based Data Currently Being Generated by 19 Ongoing Studies Using IceCure Medical's ProSense Cryoablation System

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification PR Newswire CAESAREA, Israel, Nov. 3, 2023...

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate...

IceCure's ICE3 Trial Results Demonstrating 96.91% Recurrence Free Rate Featured in a Presentation at BISICON 2023 in India

Independent Scientific Paper by Doctors Using IceCure's ProSense Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer...

Independent Scientific Paper by Doctors Using IceCure's ProSense Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

IceCure Medical management to meet with Oppenheimer

IceCure Medical Ltd. is a commercial stage medical device company. It is engaged in the research, development, and marketing of cryoablation systems, disposables, and technologies based on liquid nitrogen for treating tumors. The company was founded in 2006 and is headquartered in Caesarea, Israel.

Watchers	1,966
52-Wk Low	$0.52
52-Wk High	$4.73

Market Cap	$194.08M
Volume (M)	2,105.00
52-Wk High	$4.73
52-Wk Low	$0.52

ICCM Icecure Medical Ltd

About

Feed

News

Earnings

Fundamentals